BTKi, venetoclax, obinutuzumab: what is the ideal combination?

Heintel, D

Heintel, D (通讯作者),Klin Ottakring, Dept Oncol Hematol & Palliat Care, Montleartstr 37, A-1160 Vienna, Austria.

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022; 15 (1): 49

Abstract

Chronic lymphocytic leukemia (CLL) treatment strategies have improved and changed dramatically in the last few years. Currently, patients are mostly t......

Full Text Link